EXECUTIVE ENGAGEMENTS
POOL
INTERACTIONS
PARTICIPANTS
VALIDATIONS
COMPANIES
* Login for a full stack data experience
DATE
JAN 2023
TABLES
202
PAGES
263
EDITION
19
PRICE
USD 5600
CODE
MCP-1129
*Engagement stats are ongoing and dynamic
HIGHLIGHTS & REPORT INDEX
What`s New for 2023?
»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
»Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
»Online interactive peer-to-peer collaborative bespoke updates
»Access to our digital archives and MarketGlass Research Platform
»Complimentary updates for one year
Looking Ahead to 2023
The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.
Global Veterinary Vaccines Market to Reach $13.1 Billion by 2030
In the changed post COVID-19 business landscape, the global market for Veterinary Vaccines estimated at US$8.3 Billion in the year 2022, is projected to reach a revised size of US$13.1 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2022-2030. Porcine Vaccines, one of the segments analyzed in the report, is projected to record a 6.9% CAGR and reach US$4.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Poultry Vaccines segment is readjusted to a revised 6.1% CAGR for the next 8-year period.
The U.S. Market is Estimated at $2.4 Billion, While China is Forecast to Grow at 5.4% CAGR
The Veterinary Vaccines market in the U.S. is estimated at US$2.4 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.3 Billion by the year 2030 trailing a CAGR of 5.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.3% and 4.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.
SELECT PLAYERS
Bayer de México SA de CV; Biogénesis Bagó SA; Boehringer Ingelheim International GmbH; Ceva Santé Animale; Elanco Animal Health; Heska Corporation; Indian Immunologicals Ltd.; Merck Animal Health; Virbac SA; Zoetis Inc.
SEGMENTS
» Type (Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines, Other Types) » Technology (Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, Other Vaccines)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
I. METHODOLOGY |
II. EXECUTIVE SUMMARY |
1. MARKET OVERVIEW |
Influencer Market Insights |
World Market Trajectories |
Recent Market Activity |
Market Outlook |
Important Animal Diseases |
Veterinary Vaccines Market on a Growth Trajectory |
Livestock Vaccines Rule the Roost |
Select Animal Disease Vaccines |
Mature Markets Vis-a-vis Emerging Markets |
Veterinary Vaccines Market based on Technology |
Live Attenuated Vaccines |
Killed/Inactivated Vaccines |
Recombinant vector vaccines |
Recombinant DNA Technology to Take Over the Industry |
Vector-based Vaccines |
DNA Vaccines |
Subunit and Virus-Like Particle (VLP)-based vaccines |
Targeted Deletions/Modifications-based Vaccines |
Collaborative R&D for Various Types of Veterinary Vaccines |
Market Challenges |
Veterinary Vaccines – Global Key Competitors Percentage Market Share in 2022 (E) |
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E) |
Impact of Covid-19 and a Looming Global Recession |
2. FOCUS ON SELECT PLAYERS |
Bayer AG (Germany) |
Biogenesis Bago SA (Argentina) |
Boehringer Ingelheim International GmbH (Germany) |
Ceva Santé Animale (France) |
Elanco Animal Health (USA) |
Diamond Animal Health (USA) |
Indian Immunologicals Ltd. (India) |
Merck Animal Health (USA) |
Virbac SA (France) |
Zoetis Inc. (USA) |
3. MARKET TRENDS & DRIVERS |
Need to Ensure Sustainable Food Supply Spurs Growth |
Increasing Demand for Animal Protein in Developing Countries to Benefit the Market |
Increasing Pet Ownership Drives Demand for Companion Animal Vaccines |
Spread of Zoonotic Diseases Propels Growth of Veterinary Vaccines |
Social Concerns on Slaughtering Presents a Valid Case for Use of Vaccines |
Novel Trends in Animal Vaccine Development |
Reduced Response Time |
Drug Resistance |
Serotype Cross-Protection |
Innovative Manufacturing |
Technological Advancements |
Porcine Market Offers Significant Prospects for Growth and New Vaccine Development |
Select Swine Diseases |
Select Key Marketed Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccines |
Porcine Epidemic Diarrhea Virus (PEDV) Vaccines Available in Select Countries |
Improvised Adjuvant Usage and Veterinary Vaccine Delivery Systems |
Anthrax and Other Vaccines with Improved Adjuvants in the Pipeline |
Matrix™ Adjuvant Technology by Novavax |
Global Efforts to Conquer FMD by an Effective Vaccine |
Member Countries with Endorsed Official Control Programme for FMD |
FMD Free Zone Where Vaccination Is Practised |
Foot-and-Mouth Disease Vaccines Available |
Developments in the Poultry Vaccine Market |
Vaccination - Critical for Controlling Avian Influenza Virus |
Avian Influenza Vaccines |
New Effervescent Tablets Vaccines against NDV - Augmenting Trend towards Convenient Administration |
Vaccination in the Hatchery Gains Momentum |
Parasitic Vaccines Segment Holds Potential |
Egg-Derived Veterinary Vaccines in Human Vaccine Facilities |
New Vaccine Strains - The Imminent Need in the Vaccine Market |
The Need for Innovative Vaccine Delivery Mechanism Increasing |
More Vaccines Needed to Prevent Zoonotic Infections |
Plant-based Vaccines - the Next Avenue in Cost - effective and Efficacious Vaccines; Obstacles Persist Delaying Market Debut |
Pricing Affects the Livestock Vaccine Market |
Over-Vaccination Trend May Prove Harmful |
4. GLOBAL MARKET PERSPECTIVE |
World Recent Past, Current & Future Analysis for Veterinary Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Veterinary Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Veterinary Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Porcine Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Porcine Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Porcine Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Poultry Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Poultry Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Poultry Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Canine Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Canine Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Canine Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Bovine Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Bovine Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Bovine Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Feline Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Feline Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Feline Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Ovine Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Ovine Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Ovine Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Inactivated Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Inactivated Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Inactivated Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Live Attenuated Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Live Attenuated Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Live Attenuated Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Recombinant Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Recombinant Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Recombinant Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Toxoid Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Toxoid Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Toxoid Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Other Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Other Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Other Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
World Veterinary Vaccines Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030 |
III. MARKET ANALYSIS |
UNITED STATES |
Veterinary Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E) |
USA Recent Past, Current & Future Analysis for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
USA Historic Review for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
USA 16-Year Perspective for Veterinary Vaccines by Type - Percentage Breakdown of Value Sales for Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types for the Years 2014, 2023 & 2030 |
USA Recent Past, Current & Future Analysis for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
USA Historic Review for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
USA 16-Year Perspective for Veterinary Vaccines by Technology - Percentage Breakdown of Value Sales for Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines for the Years 2014, 2023 & 2030 |
CANADA |
Canada Recent Past, Current & Future Analysis for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Canada Historic Review for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Canada 16-Year Perspective for Veterinary Vaccines by Type - Percentage Breakdown of Value Sales for Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types for the Years 2014, 2023 & 2030 |
Canada Recent Past, Current & Future Analysis for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Canada Historic Review for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Canada 16-Year Perspective for Veterinary Vaccines by Technology - Percentage Breakdown of Value Sales for Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines for the Years 2014, 2023 & 2030 |
JAPAN |
Veterinary Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E) |
Japan Recent Past, Current & Future Analysis for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Japan Historic Review for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Japan 16-Year Perspective for Veterinary Vaccines by Type - Percentage Breakdown of Value Sales for Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types for the Years 2014, 2023 & 2030 |
Japan Recent Past, Current & Future Analysis for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Japan Historic Review for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Japan 16-Year Perspective for Veterinary Vaccines by Technology - Percentage Breakdown of Value Sales for Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines for the Years 2014, 2023 & 2030 |
CHINA |
Veterinary Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E) |
China Recent Past, Current & Future Analysis for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
China Historic Review for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
China 16-Year Perspective for Veterinary Vaccines by Type - Percentage Breakdown of Value Sales for Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types for the Years 2014, 2023 & 2030 |
China Recent Past, Current & Future Analysis for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
China Historic Review for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
China 16-Year Perspective for Veterinary Vaccines by Technology - Percentage Breakdown of Value Sales for Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines for the Years 2014, 2023 & 2030 |
EUROPE |
Veterinary Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E) |
Europe Recent Past, Current & Future Analysis for Veterinary Vaccines by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR |
Europe Historic Review for Veterinary Vaccines by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Europe 16-Year Perspective for Veterinary Vaccines by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030 |
Europe Recent Past, Current & Future Analysis for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Europe Historic Review for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Europe 16-Year Perspective for Veterinary Vaccines by Type - Percentage Breakdown of Value Sales for Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types for the Years 2014, 2023 & 2030 |
Europe Recent Past, Current & Future Analysis for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Europe Historic Review for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Europe 16-Year Perspective for Veterinary Vaccines by Technology - Percentage Breakdown of Value Sales for Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines for the Years 2014, 2023 & 2030 |
FRANCE |
Veterinary Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E) |
France Recent Past, Current & Future Analysis for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
France Historic Review for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
France 16-Year Perspective for Veterinary Vaccines by Type - Percentage Breakdown of Value Sales for Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types for the Years 2014, 2023 & 2030 |
France Recent Past, Current & Future Analysis for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
France Historic Review for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
France 16-Year Perspective for Veterinary Vaccines by Technology - Percentage Breakdown of Value Sales for Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines for the Years 2014, 2023 & 2030 |
GERMANY |
Veterinary Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E) |
Germany Recent Past, Current & Future Analysis for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Germany Historic Review for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Germany 16-Year Perspective for Veterinary Vaccines by Type - Percentage Breakdown of Value Sales for Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types for the Years 2014, 2023 & 2030 |
Germany Recent Past, Current & Future Analysis for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Germany Historic Review for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Germany 16-Year Perspective for Veterinary Vaccines by Technology - Percentage Breakdown of Value Sales for Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines for the Years 2014, 2023 & 2030 |
ITALY |
Italy Recent Past, Current & Future Analysis for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Italy Historic Review for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Italy 16-Year Perspective for Veterinary Vaccines by Type - Percentage Breakdown of Value Sales for Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types for the Years 2014, 2023 & 2030 |
Italy Recent Past, Current & Future Analysis for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Italy Historic Review for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Italy 16-Year Perspective for Veterinary Vaccines by Technology - Percentage Breakdown of Value Sales for Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines for the Years 2014, 2023 & 2030 |
UNITED KINGDOM |
Veterinary Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E) |
UK Recent Past, Current & Future Analysis for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
UK Historic Review for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
UK 16-Year Perspective for Veterinary Vaccines by Type - Percentage Breakdown of Value Sales for Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types for the Years 2014, 2023 & 2030 |
UK Recent Past, Current & Future Analysis for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
UK Historic Review for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
UK 16-Year Perspective for Veterinary Vaccines by Technology - Percentage Breakdown of Value Sales for Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines for the Years 2014, 2023 & 2030 |
REST OF EUROPE |
Rest of Europe Recent Past, Current & Future Analysis for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Rest of Europe Historic Review for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Rest of Europe 16-Year Perspective for Veterinary Vaccines by Type - Percentage Breakdown of Value Sales for Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types for the Years 2014, 2023 & 2030 |
Rest of Europe Recent Past, Current & Future Analysis for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Rest of Europe Historic Review for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Rest of Europe 16-Year Perspective for Veterinary Vaccines by Technology - Percentage Breakdown of Value Sales for Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines for the Years 2014, 2023 & 2030 |
ASIA-PACIFIC |
Veterinary Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E) |
Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Asia-Pacific Historic Review for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Asia-Pacific 16-Year Perspective for Veterinary Vaccines by Type - Percentage Breakdown of Value Sales for Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types for the Years 2014, 2023 & 2030 |
Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Asia-Pacific Historic Review for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Asia-Pacific 16-Year Perspective for Veterinary Vaccines by Technology - Percentage Breakdown of Value Sales for Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines for the Years 2014, 2023 & 2030 |
REST OF WORLD |
Rest of World Recent Past, Current & Future Analysis for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Rest of World Historic Review for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Rest of World 16-Year Perspective for Veterinary Vaccines by Type - Percentage Breakdown of Value Sales for Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types for the Years 2014, 2023 & 2030 |
Rest of World Recent Past, Current & Future Analysis for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Rest of World Historic Review for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Rest of World 16-Year Perspective for Veterinary Vaccines by Technology - Percentage Breakdown of Value Sales for Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines for the Years 2014, 2023 & 2030 |
IV. COMPETITION |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com